BridgeMD
Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial.
EU CTIS ID: 2024-511890-30-03
What this study is testing
Finding the optimal endometrial preparation protocol for transfer of a frozen-thawed embryo
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- • Women undergoing FET after a first, second or third fresh IVF/ICSI cycle
- • Single embryo transfer (SET) or Double embryo transfer (DET)
- • Female age between 18-45 year
- • Women having a natural ovulatory cycle (24-35 days)
- • Normal uterine cavity (fundal indentation at the cavity <10mm)
- • Written informed consent
You likely can't join if
- • Use of donor gametes
- • BMI > or equal to 35 kg / m2
- • Any contra-indication to estrogen or progesterone supplementation (e.g. history of thrombosis, prior or current hormone-sensitive malignancy…)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.